Literature DB >> 22933749

Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice.

Fitriya N Dewi1, Charles E Wood, Johanna W Lampe, Meredith A J Hullar, Adrian A Franke, Deborah L Golden, Michael R Adams, J Mark Cline.   

Abstract

Equol is an isoflavone (IF) metabolite produced by intestinal microbiota in a subset of people consuming dietary soy. Equol producers may show different responses to soy foods and phenotypes related to cancer risk. Here, we assessed the effects of soy IF, endogenous microbial equol production, and dietary racemic equol in a 3 × 2 × 2 factorial experiment using gnotobiotic apoE-null mice (n = 9-11/group/sex). At age 3-6 wk, equol-producing microbiota were introduced to one-half of the colony (n = 122). At age 6 wk, mice were randomized to receive a diet that contained 1 of 3 protein sources: casein and lactalbumin, alcohol-washed soy protein (low IF), and intact soy protein (high IF), with total IF amounts of 0, 42, and 566 mg/kg diet, respectively. One-half of each diet group also received racemic equol (291 mg/kg diet). After 16 wk of dietary treatment, serum isoflavonoid profiles varied with sex, soy IF amount, and intestinal microbiota status. There were no treatment effects on tissues of male mice. In females, reproductive tissue phenotypes differed by equol-producing ability (i.e., microbiota status) but not dietary equol or IF content. Equol producers had lower uterine weight, vaginal epithelial thickness, total uterine area, endometrial area, and endometrial luminal epithelial height compared with nonproducers (P < 0.05 for all), with an association between microbiota status and estrous cycle (P > chi-square = 0.03). Exogenous equol reduced expression of progesterone receptor (PGR) and the proliferation marker Ki67 (P < 0.0001) in vaginal epithelium and endometrium; for endogenous equol, only PGR was reduced (P < 0.0005). Our findings indicate that equol diminishes estrogen-dependent tissue responses in apoE-null mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22933749      PMCID: PMC3442795          DOI: 10.3945/jn.112.161711

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  56 in total

1.  Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women.

Authors:  Sanne Kreijkamp-Kaspers; Linda Kok; Michiel L Bots; Diederick E Grobbee; Johanna W Lampe; Yvonne T van der Schouw
Journal:  Am J Clin Nutr       Date:  2005-01       Impact factor: 7.045

Review 2.  Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

Authors:  Jian-Ping Yuan; Jiang-Hai Wang; Xin Liu
Journal:  Mol Nutr Food Res       Date:  2007-07       Impact factor: 5.914

3.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

4.  Estrogen metabolism and excretion in Oriental and Caucasian women.

Authors:  H Adlercreutz; S L Gorbach; B R Goldin; M N Woods; J T Dwyer; E Hämäläinen
Journal:  J Natl Cancer Inst       Date:  1994-07-20       Impact factor: 13.506

5.  Metabolism of androgens and estrogens by human fecal microorganisms.

Authors:  P Lombardi; B Goldin; E Boutin; S L Gorbach
Journal:  J Steroid Biochem       Date:  1978-08       Impact factor: 4.292

6.  Perinatal exposure to genistein alters reproductive development and aggressive behavior in male mice.

Authors:  Amy B Wisniewski; Amy Cernetich; John P Gearhart; Sabra L Klein
Journal:  Physiol Behav       Date:  2005-01-12

7.  Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback.

Authors:  Trent D Lund; Daniel J Munson; Megan E Haldy; Kenneth D R Setchell; Edwin D Lephart; Robert J Handa
Journal:  Biol Reprod       Date:  2003-12-17       Impact factor: 4.285

8.  The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

Authors:  Kenneth Dr Setchell; Xueheng Zhao; Pinky Jha; James E Heubi; Nadine M Brown
Journal:  Am J Clin Nutr       Date:  2009-08-26       Impact factor: 7.045

9.  Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats.

Authors:  D Rachoń; T Vortherms; D Seidlová-Wuttke; A Menche; W Wuttke
Journal:  Climacteric       Date:  2007-10       Impact factor: 3.005

10.  Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats.

Authors:  E Bowey; H Adlercreutz; I Rowland
Journal:  Food Chem Toxicol       Date:  2003-05       Impact factor: 6.023

View more
  4 in total

1.  Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype.

Authors:  Cara L Frankenfeld; Gertraud Maskarinec; Adrian A Franke
Journal:  Br J Nutr       Date:  2021-11-12       Impact factor: 4.125

Review 2.  The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol.

Authors:  Fatemeh Rafii
Journal:  Metabolites       Date:  2015-01-14

3.  S-equol Exerts Estradiol-Like Anorectic Action with Minimal Stimulation of Estrogen Receptor-α in Ovariectomized Rats.

Authors:  Yuri Nishimura; Kaori Mabuchi; Azusa Takano; Yayoi Hara; Hiroko Negishi; Keiko Morimoto; Tomomi Ueno; Shigeto Uchiyama; Akira Takamata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-19       Impact factor: 5.555

4.  Combined Exposure to Multiple Endocrine Disruptors and Uterine Leiomyomata and Endometriosis in US Women.

Authors:  Yuqing Zhang; Yingying Lu; Huiyuan Ma; Qing Xu; Xiaoli Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-20       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.